Acute respiratory distress syndrome (ARDS) therapeutics market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period. The market for acute respiratory distress syndrome (ARDS) is being driven by factors such as the rising prevalence and incidence of acute lung injury, a wide range of ARDS risk factors, and an increase in the number of patients who have ARDS. This...